By Dr Kurosh Parsi

Book Chapters

Parsi K, 2024, 'Dermatological manifestations of venous insufficiency', in Foam Sclerotherapy A Textbook, pp. 13 - 30, http://dx.doi.org/10.1201/9781003579779-3

Parsi K; Kang M, 2020, 'Deactivation of Detergent Sclerosants.', in Foam Sclerotherapy, CRC Press

Parsi K; Kang M, 2020, 'Interactions of Detergent Sclerosants with the Coagulation System', in Foam Sclerotherapy, CRC Press

Parsi K; Kang M, 2020, 'Role of Ultrasound and ultrasound guidance in Foam Sclerotherapy.', in Foam Sclerotherapy, CRC Press

Parsi K; Kang M, 2020, 'Tumescent-assisted Sclerotherapy (TAS)', in Foam Sclerotherapy, CRC Press

Parsi K; Kang M, 2019, 'Do all Venous Malformations Require Treatment?', in Vascular Malformations Advances and Controversies in Contemporary Management, CRC Press, pp. 149 - 152

Parsi K; Kang M, 2019, 'Foam Sclerotherapy: First option for venous malformations?', in Vascular Malformations Advances and Controversies in Contemporary Management, CRC Press

Parsi K; Kang M, 2019, 'Is this capillary malformation? Differential diagnosis and other dermal vascular lesions', in Vascular Malformations Advances and Controversies in Contemporary Management, CRC Press

Parsi K, 2019, 'Klippel-Trenaunay syndrome and complex venous malformations: Should multimodality approach be standard of care?', in Vascular Malformations Advances and Controversies in Contemporary Management, CRC Press

Parsi K, 2017, 'Complications of Endovascular Treatment of Peripheral Congenital Vascular Malformations', in Congenital Vascular Malformations, Springer

Parsi K, 2017, 'Management of Lymphatic Malformations', in Congenital Vascular Malformations, Springer

Ugolini-Lopes MR; Criado PR; Parsi K; Kucukkaya RD; Amigo M; Tektonidou M; Andrade D, 2017, 'Treatment of Non-criteria Manifestations in Antiphospholipid Syndrome', in Erkan D; Lockshin M (ed.), Antiphospholipid Syndrome, Springer, pp. 247 - 266, http://dx.doi.org/10.1007/978-3-319-55442-6_13

Parsi K, 2015, 'Dermatological Manifestations of Vascular Malformations', in Hemangiomas and Vascular Malformations An Atlas of Diagnosis and Treatment, Springer, pp. 199 - 206

Parsi K, 2014, 'Vascular malformations, tumours and fistulae', in Practical Vascular Ultrasound:An Illustrated Guide, pp. 215 - 229

Parsi K, 2013, 'Vascular Tumours, Malformations and Fistulae', in Making Sense of Vascular Ultrasound A hands-on guide, CRC Press

Parsi K, 2008, 'Dermatological Manifestations of Venous Disease.', in Foam Sclerotherapy: A Textbook, CRC Press

Journal articles

Gracé J; Connor D; Parsi K, 2025, 'Authors reply: Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents', Phlebology, 40, pp. 55 - 56, http://dx.doi.org/10.1177/02683555241271932

Cooley Andrade O; Connor DE; Chee E; Weisel JW; Parsi K, 2025, 'Spaghetti with meatballs or noodles: Microscopic structure of sclerosant-induced thrombus, sclerocoagulum and superficial venous thrombosis', Phlebology, http://dx.doi.org/10.1177/02683555251336929

Parsi K; De Maeseneer M; van Rij AM; Rogan C; Bonython W; Devereux JA; Lekich CK; Amos M; Bozkurt AK; Connor DE; Davies AH; Gianesini S; Gibson K; Gloviczki P; Grabs A; Grillo L; Hafner F; Huber D; Iafrati M; Jackson M; Jindal R; Lim A; Lurie F; Marks L; Raymond-Martimbeau P; Paraskevas P; Ramelet AA; Rial R; Roberts S; Simkin C; Thibault PK; Whiteley MS, 2024, 'Guidelines for management of actual or suspected inadvertent intra-arterial injection of sclerosants', Phlebology, 39, pp. 683 - 719, http://dx.doi.org/10.1177/02683555241260926

Xu N; Siriwardene M; Naidu N; Connor DE; Davies AH; Gloviczki P; Meissner MH; Parsi K, 2024, 'Diagnosis of post-thrombotic syndrome: International union of phlebology (UIP) survey of medical specialists', Phlebology, 39, pp. 606 - 618, http://dx.doi.org/10.1177/02683555241259616

Parsi K; Grace J; Connor D, 2024, 'Authors reply: 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure', Phlebology, 39, pp. 494 - 496, http://dx.doi.org/10.1177/02683555241239553

Tan M; Lurie F; Bauza Moreno H; Van den Bussche D; Parsi K; Davies AH, 2024, 'Management of venous leg ulcers', Phlebology, 39, pp. 488 - 491, http://dx.doi.org/10.1177/02683555241243167

Tan M; Urbanek T; Rabe E; Gianesini S; Parsi K; Davies AH, 2024, 'Compression therapy in the management of varicose veins', Phlebology, 39, pp. 276 - 279, http://dx.doi.org/10.1177/02683555231222679

Tan M; Campbell B; Parsi K; Davies AH, 2024, 'Management of bleeding varicose veins', Phlebology, 39, pp. 273 - 275, http://dx.doi.org/10.1177/02683555231219548

Tan M; Shaydakov E; Parsi K; Davies AH, 2024, 'Microsclerotherapy', Phlebology, 39, pp. 280 - 283, http://dx.doi.org/10.1177/02683555231222678

Tan M; Sadek M; Kabnick L; Parsi K; Davies AH, 2024, 'Management of endothermal heat-induced thrombosis', Phlebology, 39, pp. 214 - 217, http://dx.doi.org/10.1177/02683555231219549

Tan M; Vuylsteke M; Blebea J; Parsi K; Davies AH, 2024, 'Management of the patient with the swollen lower limb', Phlebology, 39, pp. 218 - 220, http://dx.doi.org/10.1177/02683555231219726

Parsi K; Zhang L; Whiteley MS; Vuong S; Kang M; Naidu N; Grace J; Connor DE, 2024, '899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure', Phlebology, 39, pp. 80 - 95, http://dx.doi.org/10.1177/02683555231211086

Tan M; Vedantham S; Narayanan S; Parsi K; Davies AH, 2024, 'Interventional treatment for acute iliofemoral deep venous thrombosis', Phlebology, 39, pp. 139 - 142, http://dx.doi.org/10.1177/02683555231211080

Tan M; Lurie F; Kim DI; Wakefield T; Parsi K; Davies AH, 2024, 'Management of isolated distal deep venous thrombosis', Phlebology, 39, pp. 143 - 146, http://dx.doi.org/10.1177/02683555231211095

Gracé J; Connor D; Bester L; Rogan C; Parsi K, 2024, 'Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents', Phlebology, 39, pp. 114 - 124, http://dx.doi.org/10.1177/02683555231214343

Tan M; Moreno HB; Bechter-Hugl B; Gianesini S; Connor D; Parsi K; Davies AH, 2024, 'Sclerotherapy: Indications and safety volumes', Phlebology, 39, pp. 135 - 138, http://dx.doi.org/10.1177/02683555231211092

Tan M; Bauza Moreno H; Thomis S; Canata V; Gianesini S; Parsi K; Davies AH, 2024, 'Truncal ablation: Techniques', Phlebology, 39, pp. 132 - 134, http://dx.doi.org/10.1177/02683555231211087

Zhang L; Ng K; Pham JP; Thoo S; Yang A; Kang M; Connor D; Kossard S; Parsi K, 2023, 'Pigmentation of lower limbs: Contribution of haemosiderin and melanin in chronic venous insufficiency and related disorders', Phlebology, 38, pp. 657 - 667, http://dx.doi.org/10.1177/02683555231196702

Kang M; Parsi K, 2023, 'Response to - Letter to the editor ‘Transparietal diffusion of polidocanol: Potential complication of sclerotherapy?’', Phlebology, 38, pp. 700, http://dx.doi.org/10.1177/02683555231198409

Zhang L; Kossard S; Parsi K, 2023, 'Letter to the editor re: Assessment and grading of pigmentation in chronic venous insufficiency', Phlebology, 38, pp. 417 - 418, http://dx.doi.org/10.1177/02683555231175025

Zhang L; Kang M; Kossard S; Parsi K, 2023, 'Myopericytomatosis: A rare entity mimicking other vascular tumours and malformations', Australasian Journal of Dermatology, 64, pp. 255 - 259, http://dx.doi.org/10.1111/ajd.14011

Wong M; Parsi K; Myers K; De Maeseneer M; Caprini J; Cavezzi A; Connor DE; Davies AH; Gianesini S; Gillet JL; Grondin L; Guex JJ; Hamel-Desnos C; Morrison N; Mosti G; Orrego A; Partsch H; Rabe E; Raymond-Martimbeau P; Schadeck M; Simkin R; Tessari L; Thibault PK; Ulloa JH; Whiteley M; Yamaki T; Zimmet S; Kang M; Vuong S; Yang A; Zhang L, 2023, 'Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications – A consensus document of the International Union of Phlebology-2023', Phlebology, 38, pp. 205 - 258, http://dx.doi.org/10.1177/02683555231151350

Parsi K; Connor DE, 2023, 'Authors Reply: Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses', Phlebology, 38, pp. 196 - 197, http://dx.doi.org/10.1177/02683555231153019

Parsi K; Subramaniam P; Davies AH; Gasparis A; Gloviczki P; Marston WA; Meissner M; Rogan C; van Rij A, 2022, 'Routine use of concurrent fluoroscopic imaging during superficial endovenous interventions: A position statement of the International Union of Phlebology (UIP), the Australasian College of Phlebology (ACP), the Australia and New Zealand Society for Vascular Surgery (ANZSVS), the American Venous Forum (AVF), the American Vein and Lymphatic Society (AVLS), the European College of Phlebology (ECoP) and the Interventional Radiology Society of Australasia (IRSA)', Journal of Vascular Surgery Venous and Lymphatic Disorders, 10, pp. 1198 - 1200, http://dx.doi.org/10.1016/j.jvsv.2022.07.009

Kang M; Yang A; Hannaford P; Connor D; Parsi K, 2022, 'Skin necrosis following sclerotherapy. Part 2: Risk minimisation and management strategies', Phlebology, 37, pp. 628 - 643, http://dx.doi.org/10.1177/02683555221125596

Kang M; Yang A; Hannaford P; Connor D; Parsi K, 2022, 'Skin necrosis following sclerotherapy. Part 1: Differential diagnosis based on classification of pathogenic mechanisms', Phlebology, 37, pp. 409 - 424, http://dx.doi.org/10.1177/02683555221088101

Parsi K; Kim B; O’Connor AA; Kadam P; Connor D, 2022, 'Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses', Phlebology, 37, pp. 348 - 360, http://dx.doi.org/10.1177/02683555221075813

Kang M; Connor DE; Parsi K, 2022, 'Treatment of venous malformations with tumescent-assisted sclero-embolic and ablative lasers (SEALs): Safe and effective long-term outcomes', Phlebology, 37, pp. 367 - 380, http://dx.doi.org/10.1177/02683555221080045

Kang M; Parsi K, 2022, 'Treatment of facial hypertrophic capillary malformations with tumescent-assisted sclerotherapy', Australasian Journal of Dermatology, 63, pp. 235 - 239, http://dx.doi.org/10.1111/ajd.13838

Connor D; Thibault S; Lim A; Thibault P; Parsi K, 2022, 'Professor Kenneth Arthur Myers MS, FRACS, FACS, DDU (Vasc), 14th February 1935-3rd March 2021', Phlebology, 37, pp. 72 - 74, http://dx.doi.org/10.1177/02683555211016921

Parsi K; Subramaniam P; Davies AH; Gasparis A; Gloviczki P; Marston WA; Meissner M; Rogan C; van Rij A, 2022, 'Routine use of concurrent fluoroscopic imaging during superficial endovenous interventions: A position statement of the International Union of Phlebology, the Australasian College of Phlebology, the Australia and New Zealand Society for Vascular Surgery, the American Venous Forum, the American Vein and Lymphatic Society, the European College of Phlebology and the Interventional Radiology Society of Australasia', Phlebology, http://dx.doi.org/10.1177/02683555221112735

Gracé J; Connor D; Bester L; Rogan C; Parsi K, 2021, 'LIPIODOL reduces the lytic activity of detergent sclerosants in vitro', Phlebology, 36, pp. 771 - 778, http://dx.doi.org/10.1177/02683555211018312

Parsi K; Connor D; Nicolaides A; van Rij A; Malouf M, 2021, 'Kenneth Arthur Myers (1935-2021)', Journal of Vascular Surgery Venous and Lymphatic Disorders, 9, pp. 1345 - 1346, http://dx.doi.org/10.1016/j.jvsv.2021.04.008

Wong K; Connor DE; Andrade OC; Parsi K, 2021, 'Foam bubble size is significantly influenced by sclerosant concentration for polidocanol but not sodium tetradecyl sulphate', Phlebology, 36, pp. 576 - 587, http://dx.doi.org/10.1177/0268355521995012

Back to profile page